To prove this hypothesis, we treated HCT116 and RKO CRC cells with MG132, a proteasome inhibitor, for the indicated concentrations and times, and the results showed that the protein expression of endogenous p53 significantly accumulated over time following MG132 treatment (Figure 6C). This evidence concerns the gene TP53 and colorectal carcinoma.